Evrópusambandið -
slóvakíska -
EMA (European Medicines Agency)
cabazitaxel accord
accord healthcare s.l.u. - cabazitaxel - prostatic neoplasms, kastrácia-odolný - antineoplastické činidlá - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.
Slóvakía -
slóvakíska -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
cabazitaxel ever pharma 10 mg/ml koncentrát na infúzny roztok
ever valinject gmbh, rakúsko - kabazitaxel - 44 - cytostatica
Evrópusambandið -
slóvakíska -
EMA (European Medicines Agency)
abiraterone accord
accord healthcare s.l.u. - abiraterón acetátu - prostatické nádory - endokrinná terapia - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Slóvakía -
slóvakíska -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
abiraterón aristo 500 mg filmom obalené tablety
aristo pharma gmbh, nemecko - abiraterón - 44 - cytostatica
Slóvakía -
slóvakíska -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
abiraterón aristo 250 mg tablety
aristo pharma gmbh, nemecko - abiraterón - 44 - cytostatica
Slóvakía -
slóvakíska -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
eleber 60 mg koncentrát a rozpúšťadlo na infúzny roztok
zentiva, k.s., Česká republika - kabazitaxel - 44 - cytostatica
Evrópusambandið -
slóvakíska -
EMA (European Medicines Agency)
abiraterone mylan
mylan ireland limited - abiraterón acetátu - prostatické nádory - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
Slóvakía -
slóvakíska -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
abiraterón sandoz 1000 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - abirateron - 44 - cytostatica
Slóvakía -
slóvakíska -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
abiraterón sandoz 500 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - abirateron - 44 - cytostatica
Slóvakía -
slóvakíska -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
abiraterón sandoz 250 mg filmom obalené tablety
sandoz pharmaceuticals d.d., slovinsko - abirateron - 44 - cytostatica